1. Campana D, Coustan-Smith E . Detection of minimal residual disease in acute leukemia by flow cytometry Cytometry 1999 38: 139–152
2. Campana D, Pui CH . Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance Blood 1995 85: 1416–1434
3. Orfao A, Schmitz G, Brando B, Ruiz-Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF . Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions Clin Chem 1999 45: 1708–1717
4. Macedo A, Orfao A, Gonzalez M, Vidriales MB, Lopez-Berges MC, Martinez A, San Miguel JF . Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies Leukemia 1995 9: 993–998
5. Macedo A, Orfao A, Martinez A, Vidriales MB, Valverde B, Lopez-Berges MC, San Miguel JF . Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML Br J Haematol 1995 89: 338–341